Unknown

Dataset Information

Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies.


ABSTRACT:

Background

The 2030 goal for schistosomiasis is elimination as a public health problem (EPHP), with mass drug administration (MDA) of praziquantel to school-age children (SAC) as a central pillar of the strategy. However, due to coronavirus disease 2019, many mass treatment campaigns for schistosomiasis have been halted, with uncertain implications for the programmes.

Methods

We use mathematical modelling to explore how postponement of MDA and various mitigation strategies affect achievement of the EPHP goal for Schistosoma mansoni and S. haematobium.

Results

For both S. mansoni and S. haematobium in moderate- and some high-prevalence settings, the disruption may delay the goal by up to 2 y. In some high-prevalence settings, EPHP is not achievable with current strateg

SUBMITTER: Kura K 

PROVIDER: S-EPMC7928593 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature